Mirabelone Extended-Release Tablets cannot treat prostatitis, and patients are advised to follow their doctor’s instructions. Mirabellone extended-release tablets belong to the selective β3 adrenergic receptor agonist, can act on the bladder tissue, prompting the bladder smooth muscle relaxation. Therefore, the clinical use of Mirabellone extended-release tablets for the treatment of adult overactive bladder, relieve urinary urgency, urinary frequency and other symptoms, and can not treat prostatitis, patients should not blindly use the drug to prevent aggravation of the condition. Some people are prone to urinary tract infections, tachycardia and other adverse reactions after taking Mirabelone extended-release tablets. If the patient is allergic to the drug components or the existence of poorly controlled severe hypertension, it is contraindicated to take Mirabelone extended-release tablets to avoid accidents. Commonly used therapeutic drugs for prostatitis include antibiotics such as ciprofloxacin and azithromycin, and alpha-blockers such as tamsulosin hydrochloride. It is recommended to take Mirabelone extended-release tablets as prescribed by the doctor, and not to use the drug indiscriminately or arbitrarily increase or decrease the dosage of the drug. In addition to the doctor’s prescription, the prostatitis patients should pay attention to personal hygiene care, change underwear.